RESOURCES

Blogs

Insight at the intersection of data science and real-world health

The Talking Room

Demystifying AI, LLMs and machine learning

Use Cases

How teams put the signals to work

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About us

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Peer-reviewed methodologies and validated outcomes

Latest paper

The New GLP-1 Consumer

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence what moved

SEE IT IN ACTION

Bring us a question you can’t answer.

We’ll show you what the conversation already contains, using your therapy area and your audience.

ABOUT US

About us

Where our proprietary models are trained, tested and refined

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Data scientists who speak pharma.

A team built around one problem: making real-world conversation usable at scale.

Audience Analysis for Agency Using Patient Conversations
Download

At a Glance

Challenges

  • Insufficient depth in data from social listening or research groups to derive necessary insights
  • Difficulty in effectively tracking and measuring changes for comprehensive patient intelligence

Benefits

  • Drives effectiveness in access to patient voice
  • Drives efficiency by 80%
  • Creating messaging that resonates with audience

Customer Objective

A leading Agency subscribed to DrugVoice to access secure, curated patient intelligence data over a 12-month period, with the goal to track and measure changes effectively. They sought a depth and precision of insights that surpass what social listening or research groups could provide.

Brief

Enhancing patient intelligence with DrugVoice – To leverage DrugVoice in accessing secure, curated patient intelligence which would enable effective tracking and measurement of changes over time for patients surrounding their daily routine, feelings, and experience with pre-treatment and weight loss with GIP and GLP-1s.

Solution

The Agency was able to answer their specific questions in relation to GLP-1 medications:

  • Tell me how patients describe their lives when taking GLP-1 inhibitors for weight loss?
  • Show me how sentiment is changing over time?
  • Describe the daily routine of meds, diet and exercise?
  • Show me what people talk about before they commit to take GLP-1 for weight loss.

This allowed the agency to enhance its understanding of the audience and improve the effectiveness and efficiency of its marketing efforts, ensuring that their messaging resonated with patients.

DrugVoice provides unparalleled insights into understanding your audience and their needs.

Contact Britt Gibson, Manager Global Customer Engagement, at britt@talkingmedicines.com.

Read More

#
$